Wealthfront’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Wealthfront’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-207	Closed	-$36K	–	1457
2015 Q1	$36K	Buy	207 +206	+20,600%	+$30.2K	﹤0.01%	503
2014 Q4	$0	Buy	+1	New	+$121	﹤0.01%	1188

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Wealthfront's SLXP Position: Q2 2015 in Review

Wealthfront sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 207 shares — an estimated $36K sold.

Wealthfront first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $36K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Wealthfront reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Wealthfront sold 207 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $36K.
Wealthfront first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
Wealthfront's SALIX PHARMACEUTICALS LTD DEL position peaked at $36K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Wealthfront's 13F filing for Q2 2015, filed 18 Aug 2015.